BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
See today's BioWorld
Home
» Clinical Data Soars on Viibryd Depression Nod, Sale Talk
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Clinical Data Soars on Viibryd Depression Nod, Sale Talk
Jan. 25, 2011
By
Jennifer Boggs
No Comments
Shares of Clinical Data Inc. skyrocketed 67.5 percent Monday after the FDA's late Friday approval of vilazodone in major depressive disorder quieted skeptics and positioned the Newton, Mass.-based firm as a potential takeover target.
BioWorld